The BAP1 gene helps control cell growth, repair DNA damage, and clear worn out proteins from cells. When it does not work properly, cells can survive when they should not, which can raise the chance of cancers such as uveal melanoma, mesothelioma, kidney cancer, and some skin tumors. In medicine, this gene is important because harmful inherited variants can cause BAP1 tumor predisposition syndrome, while other variants have little or no effect. Families often first learn about the BAP1 gene after several relatives develop related cancers.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for making proteins, the parts of cells that do the work. Others mostly help determine when certain processes happen, where they take place, and how strongly they occur. Taken together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To go into this topic in more detail, you can find more in the LearnHub.
Overview
BAP1Gene function
What if the gene works
The BAP1 gene helps cells repair DNA damage and control when they grow, divide, or die. It also helps regulate which genes are turned on, supporting normal tissue health.
Risk
What if the gene does not work
Pathogenic variants in the BAP1 gene can raise the chance of certain tumors, especially uveal melanoma, mesothelioma, kidney cancer, and distinctive skin growths. Effects vary, with milder or more severe variants influencing which tumors develop and when.
Treatment
What does that mean for your treatment
For pathogenic variants in the BAP1 gene, no treatment or drug choice approach specific to the BAP1 gene is currently established in clinical guidelines. In cancer care, BAP1 loss is being studied as a biomarker and possible treatment target, including in mesothelioma and uveal melanoma.
Conditions associated with BAP1
Gene function
What if the gene works
In everyday cell life, the BAP1 gene helps keep growth, repair, and gene activity in balance. Its protein works mostly in the nucleus, the part of the cell that stores DNA, and it also helps manage other control systems inside the cell. Understanding what the BAP1 gene does in the body helps show how cells stay organized over time.
Through its protein, the BAP1 gene removes small protein tags called ubiquitin (a cell control label) from selected proteins. This helps fine tune how those proteins behave, where they work, and how long they stay active.
In the nucleus, the BAP1 gene helps control how tightly DNA is packaged and which genes are turned on or kept quieter. This supports normal cell identity and organized responses to everyday signals.
The BAP1 gene supports the cell’s response to DNA damage by helping repair teams work at the right place. This helps protect the genetic instructions your cells use every day.
During routine tissue upkeep, the BAP1 gene helps coordinate when cells grow, pause, and divide. This supports orderly cell turnover and stable cell behavior.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help account for normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants have no visible effect and are simply part of natural genetic variation. At times, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
In understanding how BAP1 gene variants affect protein function, many changes make the protein too short, unstable, or unable to connect with partner proteins, leaving little or no activity. Milder variants may partly reduce its ability to remove small control tags from proteins, while more disruptive variants can shut this process down. When activity is lost to a greater degree, the cancer risk linked to the BAP1 gene may appear earlier or involve a broader pattern of tumors.
How variants are linked to conditions
Pathogenic variants in the BAP1 gene cause BAP1 tumor predisposition syndrome, an inherited condition linked to a higher lifetime risk of several cancers. The main cancers associated with BAP1 variants include uveal melanoma, mesothelioma, cutaneous melanoma, and renal cell carcinoma, along with characteristic BAP1-inactivated skin tumors. Some families also have meningioma or a wider cancer pattern, but the exact features can vary from one person to another.
A variant is not necessarily a diagnosis
Across the general population, genetic variants are common and are a normal feature of human biology. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors contribute. In some cases, though, a single well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For people with a harmful BAP1 variant, risk is driven mainly by the variant itself and family history. Extra ultraviolet (UV) exposure from sunlight or tanning beds may raise the chance of melanoma, and asbestos exposure may raise the chance of mesothelioma. Avoiding these exposures and keeping up with regular checkups can help with early detection.
Inheritance of BAP1 variants
For BAP1-related tumor predisposition syndrome, the BAP1 inheritance pattern is autosomal dominant. This means a person with a disease-causing variant in one copy of the BAP1 gene can pass it on to a son or daughter, and each child has a 50% chance of inheriting that variant. People of any sex can inherit it and pass it on. Not everyone who inherits a BAP1 variant will develop the same health problems, but the inheritance pattern itself is well established.
What does my BAP1 result mean for my family?
A harmful change in the BAP1 gene can run in families in a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry it. Each child of someone with a BAP1 change has a 1 in 2, or 50%, chance of inheriting the same result. Because of this, family members may want to discuss genetic counseling and testing.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for BAP1 variants usually uses a blood or saliva sample. A laboratory reads the DNA in the BAP1 gene to look for changes linked to BAP1 tumor predisposition syndrome, and the report may show a pathogenic variant, no relevant variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Consider BAP1 genetic testing if you or close relatives have had eye melanoma, mesothelioma, kidney cancer, or several melanomas, especially if these happened at a younger age or more than one occurred in the same person. It can help explain an inherited cancer risk and guide family testing and screening.
A genetic result is only one part of your health story
A genetic result can provide helpful insight, but how much it reveals depends on the condition and the kind of variant involved. Over time, many other factors, including lifestyle, environment, age, and medical history, also shape how the body works. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other aspects of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in someone else. Some gene changes can influence how quickly a drug is broken down, how strongly it acts in the body, or how sensitive a person is to it. These differences are common and are one reason medication response can vary from person to person.
What is Pharmacogenetics?
Pharmacogenetics focuses on how differences in a person’s genes can affect their response to medications. It examines gene drug relationships to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body processes it. Understanding this can support treatment decisions that are more informed and more individualized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the BAP1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices. If you have concerns about a medicine, side effects, or a treatment plan, discuss them with your doctor. Research on the BAP1 gene is exploring whether changes may affect response to some cancer treatments, but this is not yet part of routine prescribing.
History
The BAP1 gene entered medical research in the early 2000s as scientists studied chromosome 3 changes in uveal melanoma, a cancer that starts in the eye. In 2011, researchers linked inherited pathogenic variants in the BAP1 gene to a family cancer pattern now called BAP1 tumor predisposition syndrome. From these first observations, research expanded steadily. Doctors then recognized that the same gene could be involved in several cancers, including mesothelioma, kidney cancer, and some melanocytic skin tumors. This discovery helped explain why certain rare cancer combinations appeared in some families. Over time, descriptions became more precise, and the BAP1 gene became an important part of hereditary cancer genetics.